Clinical Trials · NCT05110794
A Multiple-Dose Study of LY3502970 in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 34
- Start date
- Nov 2021
- Locations
- 1 site, Singapore
- Primary endpoint
- PK: Maximum Observed Concentration (Cmax) of LY3502970